checkAd

    Update on the merger approval process for the combination of Novozymes and Chr. Hansen  125  0 Kommentare South Korean merger approval granted

    December 20, 2023


    Please see attachment.


    Contact information

    Investor Relations
    Disa Tuominen
    +45 6038 5826
    dkditu@chr-hansen.com

    Press Relations
    Sanne Seyer-Hansen
    +45 6038 6207
    dksash@chr-hansen.com

    Lesen Sie auch

    Attachment



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Update on the merger approval process for the combination of Novozymes and Chr. Hansen South Korean merger approval granted December 20, 2023 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com Press RelationsSanne Seyer-Hansen+45 6038 6207dksash@chr-hansen.com Attachment …